Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Disability Groups Sue to Block Delaware's End-of-Life Law
Regulatory & Compliance Disability Groups Sue to Block Delaware's End-of-Life Law

A new Delaware law intended to offer compassionate end-of-life choices to the terminally ill has instead ignited a fierce legal battle, pitting the principle of personal autonomy against the fundamental civil rights of people with disabilities. A coalition of prominent patient and disability

Health Payers Weigh the Promise and Risk of AI
Digital Health Health Payers Weigh the Promise and Risk of AI

The modern consumer can track the precise location of a pizza delivery with more clarity and real-time data than they can the status of a multi-thousand-dollar medical claim. This stark discrepancy between consumer expectations and healthcare reality is the central challenge driving health payers

Why Is HIMS Stock Such A Wall Street Battleground?
Digital Health Why Is HIMS Stock Such A Wall Street Battleground?

Hims & Hers Health, the telehealth company known by its ticker HIMS, has unequivocally become one of Wall Street's most contentious "battleground" stocks, creating a deeply polarized investment landscape that pits staunch bulls against determined bears. The company’s remarkable growth trajectory

HHS Unveils Bold AI Strategy to Transform Public Health
Digital Health HHS Unveils Bold AI Strategy to Transform Public Health

Imagine a healthcare system where hospital readmissions drop significantly, maternal health outcomes improve dramatically, and bureaucratic delays become a relic of the past—all powered by artificial intelligence. The U.S. Department of Health and Human Services (HHS) has rolled out a sweeping

Will AI Tuck-In Deals Fuel Medtech M&A Growth by 2026?
Digital Health Will AI Tuck-In Deals Fuel Medtech M&A Growth by 2026?

I'm thrilled to be speaking with James Maitland, a renowned expert in robotics and IoT applications in medicine. With a deep passion for harnessing technology to revolutionize healthcare, James has been at the forefront of analyzing trends and innovations in the medtech industry. Today, we’ll

How Can You Measure Telehealth Success with 5 Key Metrics?
Digital Health How Can You Measure Telehealth Success with 5 Key Metrics?

Imagine a world where healthcare is just a click away, where patients in remote areas receive expert care without stepping foot in a hospital, and clinicians manage packed schedules with ease through virtual platforms. This isn’t a distant dream but the reality of telehealth today. Yet, with this

Can Nuclear Fusion Transform America’s Cancer Care?
Imaging & Diagnostics Can Nuclear Fusion Transform America’s Cancer Care?

Imagine a world where a cancer diagnosis doesn’t come with the added fear of delayed treatment due to a shortage of critical medical materials. In the United States, this scenario is all too real for countless patients relying on nuclear medicine for life-saving diagnostics and therapies. The

How Can Digital Health Transform Disease Surveillance in Africa?
Digital Health How Can Digital Health Transform Disease Surveillance in Africa?

Imagine a remote village in Sub-Saharan Africa where a sudden fever outbreak goes unnoticed for weeks, silently spreading to neighboring communities because health workers rely on paper reports that take days to reach national authorities. This scenario, far too common across the continent,

Custom Roof Hatch Secures Gamma Knife at Ochsner Medical
Infrastructure & Management Custom Roof Hatch Secures Gamma Knife at Ochsner Medical

Imagine a scenario where a $7 million piece of life-saving medical equipment, weighing a staggering 21 tons, needs to be carefully lowered into a mid-20th-century building during a major renovation, all while ensuring its protection from weather and unauthorized access for years to come. This was

How Is Xeltis Revolutionizing Vascular Implants with €47.5M?
Infrastructure & Management How Is Xeltis Revolutionizing Vascular Implants with €47.5M?

Imagine a world where vascular implants don’t just act as temporary fixes but actually help the body heal itself, transforming into natural tissue over time. This vision is becoming reality thanks to Xeltis, a Netherlands-based medical technology innovator that recently secured an impressive €47.5

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later